Document is current
Any future updates will be listed below
-
Authors
Zheng, Chunwei https://orcid.org/0000-0002-2084-5567
Zhang, Gangming https://orcid.org/0000-0002-8488-2607
Dean, Lilia J. https://orcid.org/0009-0001-2225-6395
Sontheimer, Erik J. https://orcid.org/0000-0002-0881-0310
-
Funding
Funding for this research was provided by:
Foundation for the National Institutes of Health (R01GM150279)
Foundation for the National Institutes of Health (P01HL158506)
Foundation for the National Institutes of Health (UH3HL147367)
Friedreich's Ataxia Research Alliance
Cystic Fibrosis Foundation
- License Information
-
More Information
Article History
Received: 23 June 2024
Accepted: 17 January 2025
First Online: 17 February 2025
Competing interests
: E.J.S. is a cofounder and scientific advisor of Intellia Therapeutics and a Scientific Advisory Board member at Tessera Therapeutics. The other authors declare no competing interests.
